ECTRIMS 2016: Young MS Investigators’ Research
The session featured a study comparing MRI criteria for diagnosing MS, the role of spinal cord volume loss in predicting disease activity, and more.
Neuro News Roundup: Treating MS & Epilepsy
New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.
Interesting Neuro: Staging Alzheimer & TBI Findings
Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.
Interesting Neuro: Parkinson Rates & Zika News
Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.
Managing MS and Immunological Comorbidities
How do you approach the management of patients with multiple sclerosis and another autoimmune condition, such as psoriasis?
Interesting Neuro: Alzheimer & Parkinson insights
Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.
Clinical Trial Highlights: AAN 2016 – Part 1
From no evidence of disease activity in MS to studies of a new treatment for periodic paralysis, AAN 2016 featured many exciting clinical trials.
Case-Based Considerations in MS Treatments
Interactive case study discussions highlighted the issue that treating multiple sclerosis often involves swimming murky waters.
Neuro News Roundup: Decreasing Impact of MS
Three new studies on multiple sclerosis discuss potential ways to prevent the development of cognitive problems, or the development of the disease.
Predicting Multiple Sclerosis Risk: GEMS Project
By studying first-degree relatives of patients with MS, can researchers perfect a risk algorithm for the disease?